Zacks Investment Research
03 Sept 2026, 15:50 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
4 claims · each scored for market impact
The Clorox Company's fourth quarter fiscal 2026 gross margin contracted 520 basis points year-over-year to 41.3%. — A significant margin contraction indicates an inability to pass on costs to consumers or manage operational expenses effectively.
-0.60Clorox expects input-cost inflation to remain sticky in fiscal 2027 due to volatile energy, commodity markets, and logistics expenses. — Persistent inflationary headwinds suggest that profitability will remain under pressure for the foreseeable future.
-0.40The company projects a fiscal 2027 gross margin of 42%, implying that cost savings may not fully offset inflationary pressures in the near term. — The guidance suggests only a marginal recovery in margins, limiting the potential for an earnings beat.
-0.30Continue reading
6 related stories
Top 2 movers · tap to explore
Clorox has completed its ERP implementation and is shifting from stabilization to optimization to capture productivity benefits. — The removal of ERP-related operational drag provides a path toward long-term structural efficiency.
+0.20Which stocks this story touches
The company is facing persistent inflationary pressure, contracting gross margins, and carries a Zacks Rank #5 (Strong Sell).
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
21m ago
